AMICUS THERAPEUTICS INC FOLD
COM · Common Stock · CUSIP 03152W109 · ISIN US03152W1099
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $14.49.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 223 |
| Q4 2022 | 231 |
| Q1 2023 | 228 |
| Q2 2023 | 218 |
| Q3 2023 | 231 |
| Q4 2023 | 230 |
| Q1 2024 | 256 |
| Q2 2024 | 261 |
| Q3 2024 | 294 |
| Q4 2024 | 291 |
| Q1 2025 | 290 |
| Q2 2025 | 274 |
| Q3 2025 | 288 |
| Q4 2025 | 332 |
| Q1 2026 | 298 |
| Q2 2026 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 147 | 118 |
| Q4 2024 | 134 | 144 |
| Q1 2025 | 152 | 126 |
| Q2 2025 | 151 | 131 |
| Q3 2025 | 157 | 124 |
| Q4 2025 | 191 | 131 |
| Q1 2026 | 152 | 168 |
| Q2 2026 | 0 | 284 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2025 | $9.4m | $9.2m | 0.98 |
| Q4 2025 | $18.8m | $23.1m | 1.23 |
| Q1 2026 | $9.2m | $6.8m | 0.73 |
| Q2 2026 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| BlackRock, Inc. | Sold out | -33.9m |
| UBS Group AG | Sold out | -16.0m |
| VANGUARD CAPITAL MANAGEMENT LLC | Sold out | -14.0m |
| Pentwater Capital Management LP | Sold out | -14.0m |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Sold out | -14.0m |
| STATE STREET CORP | Sold out | -12.9m |
| GLAZER CAPITAL, LLC | Sold out | -12.7m |
| FIL Ltd | Sold out | -12.6m |
| GOLDMAN SACHS GROUP INC | Sold out | -11.6m |
| Qube Research & Technologies Ltd | Sold out | -8.8m |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| BlackRock, Inc. 13G · institution -1.9 pts · filed 2025-04-23 | 7.4% |
| BARCLAYS PLC 13G · institution new · filed 2026-05-14 | 5.7% |
| UBS Group AG 13G · institution new · filed 2026-05-07 | 5.5% |
| VANGUARD CAPITAL MANAGEMENT LLC 13G · institution new · filed 2026-04-29 | 5.2% |
Fell to 5% or below in the last year: GOLDMAN SACHS GROUP INC (0.0%, 2026-08-12), GLAZER CAPITAL, LLC (0.0%, 2026-05-01), VANGUARD GROUP INC (0.0%, 2026-03-26; now reported by VANGUARD CAPITAL MANAGEMENT LLC), WELLINGTON MANAGEMENT GROUP LLP (0.4%, 2026-02-10), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (3.4%, 2026-02-09), Avoro Capital Advisors LLC (4.9%, 2025-11-14)
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| IFP Advisors, Inc 0.00% of their portfolio | 796 $11.5k | Reduced -18 |
| HUNTINGTON NATIONAL BANK 0.00% of their portfolio | 1 $14 | Unchanged |